About this trial
This study will be a two-arm RCT, to examine the effects of an entirely virtual, 6-month supervised PA program plus standard exercise counselling (PA+EC) versus a supervised PA plus motivationally-enhanced behavioral counselling (PA+BC) on moderate to vigorous physical activity (MVPA) in cancer survivors. A 6-month post intervention follow-up (T2) and 1-year post intervention follow-up (T3; 1-year follow-up from post-intervention) will take place after the intervention to address maintenance. The intervention is designed using evidence-based research in the fields of exercise oncology using effective clinical design and theoretical approaches, including behaviour change techniques, to gradually increase MVPA to at least 90 minutes per week in cancer survivors as per the exercise guidelines for cancer survivors.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
≥18 years of age
Confirmed diagnosis of cancer of any type (Stages I to III; localized)
Have completed primary cancer treatment within 5 years
At least 12 weeks after surgery completion
Disqualifiers
A medical condition that prohibits PA (e.g., joint restriction or weight bearing precautions)
Uncontrolled comorbidities or cardiovascular contraindications that would increase risk associated with supervised and unsupervised exercise (e.g., cardiac contraindications, severe arthritis, recent fall within the last 6-12 months)
Presence of advanced cancer (i.e., Stage IV; metastatic)
Pregnancy
Trial design
Parallel
Treatments tested in this trial
Behavioural Counselling
Other interventionThe PA+BC group will receive a behavioural counselling support session with a QEP every two weeks during the intervention period (12 total). Of the 12 video-conferencing calls, one session will target reflective processes (instrumental/affective attitudes), five sessions will target behavioural regulation (action planning, coping planning, social support, goal setting), and four sessions will target reflexive processing (self-regulation, habit). The remaining two sessions are "booster sessions" to revisit topics discussed. The importance of sustaining PA for clinical outcomes (e.g., fatigue) and PA logs will be stressed. At the end of the 6-month program, an individualized PA prescription will be provided based on their fitness level (adjusted throughout) to continue achieving the PA goal for the 6-month post intervention and 1-year post intervention follow-up.
Exercise Counselling
Other interventionThe PA+EC group will receive the same frequency of group-based and 1:1 counseling support sessions via Zoom as PA+BC participants. However, the focus will be on exercise training principles for proper PA technique, how to monitor intensity, and progress PA safely to achieve the PA guidelines.
Treatment groups
Trial outcomes
Primary outcomes
Moderate-to-Vigorous Physical Activity
Changes in MVPA will be assessed by accelerometry (ActiGraph Inc., Pensacola, FL.; model GT3X +). Participants will be mailed an accelerometer to wear on their right hip, fastened to a belt worn around the waist. The accelerometer will be worn during waking hours for 7 days, except when bathing or swimming.
Secondary outcomes
6-Minute Walk Test
6-minute walk test for aerobic endurance; from the Senior Fitness Test . Further distance walked indicates better physical function.
30-s Chair Stand Test
30-s chair stand test for lower body strength; from the Senior Fitness Test . Higher scores indicates better physical function.
Self-reported Physical Activity
Physical activity will be measured using a modified version of the (GLTEQ) Godin-Leisure Time Exercise Questionnaire 66 . This measure asks participants to self-report the frequency and duration of light, moderate, vigorous aerobic PA and resistance training for a typical week.
Functional Assessment of Cancer Therapy-General
Quality of life will be assessed by the validated Functional Assessment of Cancer Therapy-General (FACT-G) which consists of physical well-being (PWB), functional well-being (FWB), emotional well-being (EWB), and social well-being (SWB). 75
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
University of Toronto
Lead sponsor
Toronto Rehabilitation Institute
Collaborator
University of British Columbia
Collaborator